Analysis of antifungal prescriptions in a Basic Health Unit in the Federal District
DOI:
https://doi.org/10.17058/reci.v14i4.19123Keywords:
Antifungal Agents, Primary Health Care, Drug Utilization, PharmacoepidemiologyAbstract
Background and Objectives: the inappropriate use of antifungal agents leads to the development of resistance and a lack of treatment effectiveness, which can result in the worsening of clinical condition, persistent infections, increased hospitalization rates and prolonged hospital stays as well as deaths and higher healthcare costs. This study aimed to analyze antifungal prescriptions in a Basic Health Unit in the Federal District Southern Health Region, Brazil. Methods:this was a cross-sectional, descriptive, and observational study, in which the duplicate copies of prescriptions retained at the pharmacy were assessed. Results: a total of 69 prescriptions dispensed in October 2019 were analyzed. Concerning medication prescription according to the Brazilian Common Denomination (DCB) and the verification of the presence of antifungal agents in the Federal District’s List of Essential Medications (REME-DF), rates above 90% were found in the analyzed documents. Only one prescription contained the combination of two antifungal agents. The predominant prescribing category was nursing, followed by physicians and dentists. The most prescribed antifungal agents were fluconazole and miconazole. The routes of administration present in prescriptions were oral and topical. Conclusion: the lack of studies on antifungal use in primary care highlights the importance of this investigation for producing specialized knowledge on the subject.
Downloads
References
Brasil. Ministério da Saúde. Portaria nº 2.436, de 21 de setembro de 2017. Aprova a Política Nacional de Atenção Básica, estabelecendo a revisão de diretrizes para a organização da Atenção Básica no âmbito do Sistema Único de Saúde (SUS). 2017. Disponível em: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2017/prt2436_22_09_2017.html
Donnelly C, Leclair L, Hand C, et al. Occupational therapy services in primary care: a scoping review. Prim Health Care Res Dev. 2023; 24: e7. https://doi.org/10.1017/S1463423622000123
Barros DSL, Santos FMC dos, Teixeira TB. Análise das prescrições de anti-hipertensivos em unidade da atenção primária à saúde do Distrito Federal. Rev Cont Saúde. 2023; 23 (47): e11962. https://doi.org/10.21527/2176-7114.2023.47.11962
Barros DSL, Damascena HL, Gomes AR, et al. Análise de prescrições de psicofármacos em uma unidade básica de saúde do Distrito Federal. Rev Gestão Saúde. 2023; 14 (1):37-50. https://doi.org/10.26512/gs.v14i1.37428
Moura RA de, Henriques BD, Ferreira DC, et al. Atendimento à demanda espontânea na Estratégia Saúde da Família: práticas e reflexões de um processo em construção. Physis. 2022; 32 (1): e320103. https://doi.org/10.1590/S0103-73312022320103
Kavanagh KT, Cormier LE. Viewpoint: Patient safety in primary care - patients are not just a beneficiary but a critical component in its achievement. Medicine (Baltimore). 2023; 102 (37): e35095. https://doi.org/10.1097/MD.0000000000035095
Ribeiro SP, Cavalcanti MLT. Atenção Primária e Coordenação do Cuidado: dispositivo para ampliação do acesso e a melhoria da qualidade. Ciênc Saúde Coletiva. 2020; 25 (5): 1799–808. https://doi.org/10.1590/1413-81232020255.34122019
Barros DSL, Silva DLM, Leite SN. Clinical pharmaceutical services in primary health care of the Federal District: Performance frequency and conditioning factors. Braz J Pharm Sci. 2022; 58: e20029. https://doi.org/10.1590/s2175-97902022e19029
Peixoto RT, Campos MR, Luiza VL, et al. O farmacêutico na Atenção Primária à Saúde no Brasil: análise comparativa 2014-2017. Saúde debate. 2022; 46 (133): 358–75. https://doi.org/10.1590/0103-1104202213308
Piquer-Martinez C, Urionagüena A, Benrimoj SI, et al. Integration of community pharmacy in primary health care: The challenge. Res Social Adm Pharm. 2022; 18 (8): 3444-47. https://doi.org/10.1016/j.sapharm.2021.12.005
Carvalho HEF, Sousa ÁFL, Almeida CAPL, et al. Análise de prescrições de antimicrobianos na Atenção Primária à Saúde. Rev Esc Enferm USP. 2020; 54: e03607. https://doi.org/10.1590/S1980-220X2018046903607
Benedict K, Smith DJ, Chiller T, et al. Topical Antifungal Prescribing for Medicare Part D Beneficiaries — United States, 2021. MMWR Morb Mortal Wkly Rep. 2024; 73:1–5. https://doi.org/10.15585/mmwr.mm7301a1
Al Balushi KA, Alzaabi MA, Alghafri F. Prescribing Pattern of Antifungal Medications at a Tertiary Care Hospital in Oman. J Clin Diagn Res. 2016; 10 (12): FC27-30. https://doi.org/10.7860/JCDR/2016/23591.9005
Stefano ICA, Conterno LO, da Silva CR, Marin MJS. Medication use by the elderly: analysis of prescribing, dispensing, and use in a medium-sized city in the state of São Paulo. Rev bras geriatr gerontol. 2017Sep;20(5):679–90. https://doi.org/10.1590/1981-22562017020.170062
Jasso L, Lifshitz A, Arrieta O, et al. Importance of the list of essential medicines in medical prescription. Importancia del cuadro básico de medicamentos en la prescripción médica. Gac Med Mex. 2020; 156 (6): 598-59. https://doi.org/10.24875/GMM.M21000496
Jhaj R, Banerjee A, Kshirsagar NA, et al. Use of drugs not listed in the National List of Essential Medicines: Findings from a prescription analysis by the Indian Council of Medical Research-Rational Use of Medicines Centres Network in tertiary care hospitals across India. Indian J Pharmacol. 2022; 54 (6): 407-16. https://doi.org/10.4103/ijp.ijp_878_21
Leekha S, Terrell CL, Edson RS. General principles of antimicrobial therapy. Mayo Clinic proceedings, 2011; 86 (2), 156–67. https://doi.org/10.4065/mcp.2010.0639
Van Heuverswyn J, Valik JK, Desirée van der Werff S, et al. Association Between Time to Appropriate Antimicrobial Treatment and 30-day Mortality in Patients With Bloodstream Infections: A Retrospective Cohort Study. Clin Infect Dis. 2023; 76 (3): 469-78. https://doi.org/10.1093/cid/ciac727
Dias FS, Santos TA. Avaliação e comparação dos indicadores de qualidade das prescrições medicamentosas de controlados e antibióticos dispensados em uma farmácia pública e outra privada. REAS. 2020; (55): e3959. https://doi.org/10.25248/reas.e3959.2020
Farias AD, Cardoso MAA, Medeiros ACD, et al. Indicadores de prescrição médica nas unidades básicas de Saúde da Família no município de Campina Grande, PB. Rev Bras Epidemiol. 2007; 10 (2): 149–56. https://doi.org/10.1590/S1415-790X2007000200003
Alqahtani MS, Kazi M, Alsenaidy MA, et al. Advances in Oral Drug Delivery. Front Pharmacol. 2021; 12: 618411. https://doi.org/10.3389/fphar.2021.618411
Souza S, Rocha PK, Cabral PFA et al. Use of safety strategies to identify children for drug administration. Acta Paul Enferm. 2014; 27(1): 06–11. https://doi.org/10.1590/1982-0194201400003
Lima RF, Radinz DL, Carneiro RG, et al. Análise de prescrições de uma Unidade Básica de Saúde na perspectiva da segurança do paciente. Rev Cont Saúde. 2023; 23(47): e12147. https://doi.org/10.21527/2176-7114.2023.47.12147
Santos-Willshere J, Pizarro N. Introducing nurse prescribing in Gibraltar: the impact on palliative care. Br J Nurs. 2022; 31(3): 162-68. https://doi.org/10.12968/bjon.2022.31.3.162
Mills T, Patel N, Ryan K. Pharmacist non-medical prescribing in primary care. A systematic review of views, opinions, and attitudes. Int J Clin Pract. 2021; 75 (3): e13827. https://doi.org/10.1111/ijcp.13827
Raghunandan R, Howard K, Marra CA et al. Identifying Community Pharmacist Preferences For Prescribing Services in Primary Care in New Zealand: A Discrete Choice Experiment. Appl Health Econ Health Policy. 2021; 19 (2): 253-66. https://doi.org/10.1007/s40258-020-00615-3
Sedik S, Wolfgruber S, Hoenigl M, Kriegl L. Diagnosing fungal infections in clinical practice: a narrative review. Expert Rev Anti Infect Ther. 2024;1–15. doi:10.1080/14787210.2024.2403017
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Débora Santos Lula Barros, Pedro Juan Ribeiro Calisto dos Santos, Thayanne Nara da Rocha
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author must state that the paper is original (has not been published previously), not infringing any copyright or other ownership right involving third parties. Once the paper is submitted, the Journal reserves the right to make normative changes, such as spelling and grammar, in order to maintain the language standard, but respecting the author’s style. The published papers become ownership of RECI, considering that all the opinions expressed by the authors are their responsibility. Because we are an open access journal, we allow free use of articles in educational and scientific applications provided the source is cited under the Creative Commons CC-BY license.
